IRME (IR-Med) OCF Margin %: 0.00% (As of Jun. 2025)


What is IR-Med OCF Margin %?

IR-Med IRME OCF Margin % is 0.00% as of Jun. 2025. The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, IR-Med ranks worse than 122699.26% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. IR-Med's Cash Flow from Operations for the three months ended in Jun. 2025 was $-0.07 Mil. IR-Med's Revenue for the three months ended in Jun. 2025 was $0.00 Mil. Therefore, IR-Med's OCF Margin % for the quarter that ended in Jun. 2025 was 0.00%.

As of today, IR-Med's current OCF Yield % is -108.70%.

The historical rank and industry rank for IR-Med's OCF Margin % or its related term are showing as below:


IRME's OCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.86
* Ranked among companies with meaningful OCF Margin % only.

IR-Med OCF Margin % Related Terms

IR-Med OCF Margin % Historical Data

* Premium members only.

The historical data trend for IR-Med's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IR-Med OCF Margin % Chart

IR-Med Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
OCF Margin %
0.00 0.00 0.00 0.00 0.00

IR-Med Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IR-Med OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

IR-Med's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-1.386/0
= %

IR-Med's OCF Margin for the quarter that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-0.071/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
IR-Med (IRME) has a OCF Margin % of 0.00% as of Jun. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on IR-Med and its competitors. According to the industry distribution chart, IR-Med ranks #999999 out of 815 companies in the Medical Devices & Instruments industry.
Is IR-Med's OCF Margin % too high?
IR-Med's current OCF Margin % is 0.00%. Based on the distribution chart, IR-Med ranks #999999 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does IR-Med's OCF Margin % compare to SSKN and NUMD?
According to the Medical Devices & Instruments industry distribution chart, IR-Med ranks #999999 out of 815 companies for OCF Margin %. This places IR-Med in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on IR-Med and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IR-Med's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IR-Med stock overvalued right now?
IR-Med (IRME) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For IR-Med (IRME), the current OCF Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IR-Med Business Description

Address Z.H.R Industrial Zone, P.O. Box 143, Rosh Pina, ISR, 1231400
IR-Med Inc is a development-stage medical device company that is developing its technology through its Subsidiary and utilizing Infra-Red-light spectroscopy (IR) combined with Artificial Intelligence (AI) technology to develop non-invasive devices for various medical indications. These devices detect and measure biomarkers and molecules in blood and human tissue in real-time.